Press Releases
|
Announcement
Replace.
Restore.
Reimagine.
Striving to transform the treatment of disease by harnessing the power of cell therapy
At the cutting edge of science, cell therapy... the next frontier
We are a clinical stage cell therapy company that approaches science like an artist approaches a blank canvas: with creativity, passion and a desire to create something with lasting impact.
We are investigating the potential of cell therapy to replace cells that are damaged or lost to disease in order to create medicines in a new way.
News
BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery and manufacture of regulatory T cell (Treg) based therapies
BlueRock’s neuronal stem cell therapy for Parkinson’s disease is first to show positive results in Phase I clinical study
Life at BlueRock: Patty Sachamitr
BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery and manufacture of regulatory T cell (Treg) based therapies
BlueRock’s neuronal stem cell therapy for Parkinson’s disease is first to show positive results in Phase I clinical study
Life at BlueRock: Patty Sachamitr
Creating next-generation medicines for patients in need
Replace damaged cells
Restore function
Reimagine what can be possible with cellular medicine
The Courage to Ask, “What If?”
At BlueRock, we’re driven to transform the treatment of degenerative diseases, to turn “What if?” into “Here’s how.”
Learn about the science of BlueRock
Question everything.
BlueRockers are driven by the relentless pursuit of an audacious goal—to transform the way degenerative diseases are treated.
Learn about life at BlueRock
Cutting edge science.
A world of potential.
We strive to evolve the treatment of disease, moving away from traditional treatment options to investigating the replacement of cells damaged or lost to disease—starting with Parkinson’s disease.
Learn more about our programs in clinical development.
